22nd International Conference on Drug-Drug Interactions (DDI-2019)

BioIVT is proud to sponsor the 22nd International Conference on Drug-Drug Interactions, June 20-22, 2019 at the University of Washington, Seattle.
Join us, and your colleagues in ADME Tox research for an engaging discussion of state-of-the-art methods to investigate DDIs.

Dr. Kenneth Brouwer, VP, ADME-Tox at BioIVT will co-chair Session 7, entitled “Drug-Induced Liver Injury” on June 22 and will give a presentation entitled “Evaluation of BSEP Inhibition and Compensatory Mechanisms in Drug Development”

Request a Meeting

 

Visit DDI’s site to register for the event.